Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|February 4, 2014
Compliance Packaging
Gary Rice, RPh, MS, MBA, vice president of clinical services at Diplomat Specialty Pharmacy, discusses compliance packaging options.
Advertisement
Gary Rice, RPh, MS, MBA, vice president of clinical services at Diplomat Specialty Pharmacy, discusses compliance packaging options.
This video was shot at the 2013 Academy of Managed Care Pharmacy Nexus Meeting in San Antonio, Texas.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
After 180 Years, Multiple Myeloma Gets a Definition of Cure
2
Alcohol and GLP-1 Therapy: Key Counseling Points for Pharmacists
3
Severe Asthma's Effects May Extend Beyond the Lungs, Brain Imaging Study Suggests
4
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
5